Clinical Trial Update: PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating PSMA-PET directed radiation therapy for high-risk prostate cancer. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Prostate Cancer | Phase 2 | Status: NOT_YET_RECRUITING